Tower Research Capital LLC (Trc) Lantern Pharma Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.29 Billion
Q1 2025

A detailed history of Tower Research Capital LLC (Trc) transactions in Lantern Pharma Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 792 shares of LTRN stock, worth $3,318. This represents 0.0% of its overall portfolio holdings.

Number of Shares

792

Previous 1,263 37.29%

Holding current value

$3,318

Previous $4,000 50.0%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$3.3 - $5.42 $1,554 - $2,552	-471 Reduced 37.29%	792 $2,000
Q4 2024 Feb 13, 2025	SELL	$2.9 - $4.26 $730 - $1,073	-252 Reduced 16.63%	1,263 $4,000
Q3 2024 Nov 14, 2024	BUY	$3.42 - $4.83 $601 - $850	176 Added 13.14%	1,515 $5,000
Q2 2024 Aug 13, 2024	SELL	$3.91 - $9.51 $7,886 - $19,181	-2,017 Reduced 60.1%	1,339 $6,000
Q1 2024 May 15, 2024	BUY	$3.73 - $10.65 $8,176 - $23,344	2,192 Added 188.32%	3,356 $29,000
Q4 2023 Feb 13, 2024	SELL	$2.48 - $4.39 $1,718 - $3,042	-693 Reduced 37.32%	1,164 $4,000
Q3 2023 Nov 14, 2023	SELL	$3.41 - $5.51 $1,643 - $2,655	-482 Reduced 20.61%	1,857 $6,000
Q2 2023 Aug 14, 2023	BUY	$4.56 - $6.02 $1,012 - $1,336	222 Added 10.49%	2,339 $13,000
Q1 2023 May 09, 2023	BUY	$4.3 - $6.2 $8,982 - $12,951	2,089 Added 7460.71%	2,117 $10,000
Q4 2022 Feb 10, 2023	SELL	$4.19 - $6.04 $15,875 - $22,885	-3,789 Reduced 99.27%	28 $0
Q3 2022 Nov 10, 2022	BUY	$4.59 - $6.5 $12,347 - $17,485	2,690 Added 238.69%	3,817 $19,000
Q2 2022 Aug 15, 2022	BUY	$4.82 - $7.45 $1,706 - $2,637	354 Added 45.8%	1,127 $6,000
Q1 2022 May 12, 2022	SELL	$5.6 - $8.22 $4,698 - $6,896	-839 Reduced 52.05%	773 $6,000
Q4 2021 Feb 14, 2022	BUY	$7.11 - $11.04 $7,693 - $11,945	1,082 Added 204.15%	1,612 $13,000
Q3 2021 Nov 15, 2021	BUY	$10.53 - $14.93 $1,874 - $2,657	178 Added 50.57%	530 $6,000
Q2 2021 Aug 16, 2021	BUY	$12.94 - $19.89 $3,752 - $5,768	290 Added 467.74%	352 $5,000
Q1 2021 May 17, 2021	SELL	$14.34 - $21.92 $7,614 - $11,639	-531 Reduced 89.54%	62 $1,000
Q4 2020 Feb 16, 2021	SELL	$15.1 - $20.69 $1,751 - $2,400	-116 Reduced 16.36%	593 $11,000
Q3 2020 Nov 16, 2020	BUY	$10.7 - $21.25 $5,767 - $11,453	539 Added 317.06%	709 $13,000
Q2 2020 Aug 13, 2020	BUY	$11.54 - $14.95 $1,961 - $2,541	170 New	170 $2,000

Others Institutions Holding LTRN

# of Institutions

Shares Held

2.37M

Call Options Held

17.1K

Put Options Held

1.3K

View Full List

About Lantern Pharma Inc.

Ticker LTRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,830,900
Market Cap $45.4M
Description
Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...

More about LTRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Lantern Pharma Inc. Transaction History